Upfront Value




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Upfront Value
Released on: July 01, 2007. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In the July edition of the Business Report, we take a look at the value of upfront payments in licensing deals.
  • Summary
  • Transcript
  • Company
In the July edition of the Business Report, we take a look at the value of upfront payments in licensing deals. Upfront payments are an important source of cash to biotechnology companies and there have been a number of deals recently involving substantial upfront cash payments paid to licensors. In the report, we present data showing that although the average size of upfront payments is certainly increasing at an impressive rate, they are still failing to keep up with the increase in the total potential size of these deals, meaning that they represent a smaller proportion of the overall deal value.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
PharmaTelevision
PharmaTelevision® is the groundbreaking online TV channel for the biopharma industry, offering daily television news, analysis and feature interviews with industry leaders. Since May 2006, it has rapidly grown and the channel now boasts a global audience of 10,000+ viewers including top industry executives.